| BSE: 524520 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE879K01018 |
| BSE 00:00 | 24 May | 13.38 |
0.48 (3.72%) |
OPEN
13.55 |
HIGH
14.95 |
LOW
12.55 |
| NSE 05:30 | 01 Jan | KMC Speciality Hospitals (India) Ltd |
| OPEN | 13.55 |
| PREVIOUS CLOSE | 12.90 |
| VOLUME | 6325 |
| 52-Week high | 20.45 |
| 52-Week low | 9.55 |
| P/E | 29.73 |
| Mkt Cap.(Rs cr) | 218 |
| Buy Price | 13.35 |
| Buy Qty | 10.00 |
| Sell Price | 13.50 |
| Sell Qty | 100.00 |
4.07 pm | 26 May 2019 | Business Standard
While it continues to work on integrating Unichem in its specialty model, Torrent Pharma will focus on overseas geographies like US, Brazil and German...
12.06 am | 26 May 2019 | Business Standard
Fortis has said it is working on balance sheet strengthening through portfolio optimisation and non-core asset monetisation
8.52 am | 24 May 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
12.09 am | 23 May 2019 | Business Standard
Higher competitive intensity, increasing investments, and moderate growth could weigh on returns
8.06 pm | 22 May 2019 | Business Standard
Mylan will launch the product during this quarter; global market size of the generic is $7 billion
11.59 am | 22 May 2019 | Business Standard
Earlier this week, the markets recorded their best single-day gain in a decade with the Sensex surging 1,422 points as exit polls showed the incumbent...
11.34 pm | 21 May 2019 | Business Standard
Further correction in stock could present a buying opportunity
10.06 am | 21 May 2019 | Business Standard
The drug firm had posted a consolidated profit of Rs 228 crore in the year-ago quarter.
2.11 am | 21 May 2019 | Business Standard
NCLT had earlier cancelled the resolution plan by US-based Ingen Capital after it refused to infuse the upfront amount, seeking certain data from the ...
2.57 pm | 20 May 2019 | Business Standard
On the YoY basis, the company's gross margin declined by around 100 bps, primarily on account of price erosion, partially offset by new launches and f...
11.22 pm | 19 May 2019 | Business Standard
Biologics accounted for 27% of total revenue in FY19
3.17 am | 18 May 2019 | Press Trust of India
Jubilant Life Sciences Friday reported a net loss of Rs 100.65 crore in the fourth quarter ended March 31, 2019 on account of a one time loan settleme...
11.48 pm | 17 May 2019 | Business Standard
Divestment of derma assets, lower operating costs helped firm post higher profit growth during the quarter
6.58 pm | 17 May 2019 | Press Trust of India
According to FDA's definitions, Official Action Indicated means "objectionable conditions were found and regulatory and/or administrative sanctions by...
11.13 am | 17 May 2019 | Business Standard
Next week, on Thursday, May 23, Merck will turn ex-dividend for Rs 440 per share, which includes a one-time special dividend of Rs 416 per share on ac...
10.06 am | 17 May 2019 | Business Standard
Aurobindo Pharma has already submitted its initial response to USFDA
8.50 am | 17 May 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
5.19 pm | 16 May 2019 | Bloomberg
US inspectors cite Cadila Healthcare and Alkem Laboratories--both makers of valsartan--for quality-control failures.
10.12 am | 16 May 2019 | Business Standard
The stock dipped 6 per cent to Rs 736 on Thursday, extending its previous day's 3 per cent declined on the BSE.
11.03 pm | 15 May 2019 | Business Standard
Piramal says the company would look at a CAGR of 20 per cent over the next decade, despite the subdued property markets
